Skip to navigationSkip to contentSkip to footerHelp using this website - Accessibility statement
  • Sigma Healthcare Limited

    The traditional full line pharmacy wholesale distribution business, retail and private label products. Also has national Presence in the hospital pharmacy distribution market, and through its network infrastructure, provides third party and fourth party logistics services. The Group also operates one of Australia's pharmacy networks, across the brands Amcal, Guardian, Chemist King, Discount Drug Stores, WholeLife, and PharmaSave.

    SIG$1.245
     0.010 0.81%

    Data last updated:May 20, 2024 – 3.58pm. Data is 20 mins delayed.

    Previous Close

    1.235

    Open

    1.240

    Day Range

    1.228 - 1.250

    52 Week Range

    0.606 - 1.350

    Volume

    4,546,746

    Value

    4,639,638

    Bid

    1.240

    Ask

    1.245

    Dividend Yield

    0.80%

    P/E Ratio

    280.68

    Market Cap

    2.032B

    Total Issue

    1,631,866,135

    ASX Announcements

    Notification of cessation of securities - SIG

    Appendix 3H (Notification of cessation of securities)

    • May 9, 2024
    • 4 pages

    Notification regarding unquoted securities - SIG

    Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities)

    • May 9, 2024
    • 6 pages

    Becoming a substantial holder

    Becoming a substantial holder

    • May 6, 2024
    • 4 pages

    Market Sensitive

    ZSP: Boral Limited to be removed from the S&P/ASX 200 Index

    Standard and Poor’s Announcement

    • May 2, 2024
    • 2 pages

    Appendix 4G

    Appendix 4G

    • Apr 29, 2024
    • 14 pages

    View all SIG announcements

    April

    Chemist Warehouse’s deal to list via Sigma Healthcare is part way through an ACCC merger review.

    How Chemist Warehouse can get its deal past the ACCC

    Divestments may be needed to get the Chemist Warehouse/Sigma deal over the line, but they don’t look too strenuous.

    • Updated
    • Anthony Macdonald

    March

    Sigma Healthcare boss Vikesh Ramsunder and Mario Verrocchi of Chemist Warehouse.

    Chemist Warehouse sales, profit surge ahead of ASX debut

    Regulatory approval from the ACCC stands in the way of a combined Chemist Warehouse and Sigma, which have revealed robust financials before their merger.

    • Updated
    • Carrie LaFrenz and Jemima Whyte
    Chemist Warehouse’s profitability looks impressive.

    First look under the hood of Chemist Warehouse is striking

    Sigma Healthcare gave investors a little taste of the growth inside the country’s biggest pharmacy retailer on Thursday. The numbers are impressive.

    • Updated
    • James Thomson
    Federal Reserve chairman Jerome Powell unleashed the bulls.

    Jobless rate falls; Powell unleashes bulls; Chemist Warehouse surges

    Read everything that’s happened in the news so far today.

    HMC Capital’s David Di Pilla is behind Chemist Warehouse’s reverse listing through Sigma.

    The Sigma-Chemist Warehouse deal is upending all the usual rules

    If you need proof that the $8.8 billion reverse listing is unusual, cast your mind forward to the company’s results on Thursday. They’re almost irrelevant.

    • Jemima Whyte
    Advertisement

    February

    The Chanticleer podcast features James Thomson and Anthony Macdonald.

    Critical minerals bust | When will rates fall? | Elon Musk’s very bad day

    This week we try to answer the big question on the minds of markets: when are interest rates coming down; examine the critical minerals bust; and look at Elon Musk’s ‘excessive’ pay package and the Australian connection.

    January

    Jack Gance and Mario Verrocchi are set to storm onto the ASX boards.

    Chemist Warehouse blows up pharmacy regulation

    The listing of Chemist Warehouse on the ASX is the final nail in the coffin for laws designed to keep pharmacies in the hands of small business owners.

    • Tony Boyd

    December 2023

    The Chanticleer podcast features James Thomson and Anthony Macdonald.

    From stinky deals to companies to watch in 2024: Chanticleer awards

    In this week’s episode, James and Anthony wrap up 2023 with the Chanticleer Podcast awards, examine what’s ahead for markets in 2024 and help readers out with last-minute Christmas shopping.

    EY has outed itself.

    EY cuts poor performing, misbehaving partners

    More than 40 partners have left big four consulting firm EY in the second half of 2023, more than half because of poor performance, or behaviour issues.

    • Edmund Tadros
    The Chanticleer podcast features James Thomson and Anthony Macdonald.

    AFR Business People of the Year | What CEOs want | Inside Chemist Warehouse

    In this week’s episode, James and Anthony take a deep dive into what CEOs want to see from Anthony Albanese in 2024 and discuss the astounding Chemist Warehouse deal.

    Mark Finocchiaro, managing partner Chemist Warehouse, owns eight pharmacies in the group.

    Inside the Chemist Warehouse franchisee world

    There are over 200 managing partners who are shareholders in the discount chain. They are all ambitious pharmacy owners, many with multiple sites.

    • Carrie LaFrenz
    HMC Capital’s David Di Pilla has pulled off another big win.

    Chemist Warehouse deal just part of David Di Pilla’s big plan

    In helping to bring the retail giant and Sigma together, he is playing the long game and hopes to create a “mini Blackstone” in Australia.  

    • James Thomson
    Sigma’s deal suggests bulls are running and will have bankers ready to start the new year with a bang.

    Sigma’s 40pc pop: a FOMO story on a Chemist Warehouse scale

    Too bad Chemist Warehouse came just as investors are winding down for Christmas. Can the FOMO survive the break?

    • Anthony Macdonald
    Chemist Warehouse has grown into one of the largest retailers in the country and will list on the ASX through Sigma Healthcare.

    HMC Capital opens back door to Sigma-Chemist Warehouse deal

    Street Talk understands about 80 brokers tuned in for a lunchtime briefing from the asset manager on Wednesday.

    • Sarah Thompson, Kanika Sood and Emma Rapaport
    An “extraordinary” $2 billion raised this year: David Di Pilla

    David Di Pilla’s lucky streak at Sigma

    Di Pilla’s HMC will emerge with a board seat and around 3 per cent of the new company, should the deal go through

    • Sarah Thompson, Kanika Sood and Emma Rapaport
    Advertisement
    Sigma Healthcare CEO Vikesh Ramsunder, and Chemist Warehouse co-founder, Mario Verrocchi (R) both will remain in the combined business valued at $8.8 billion.

    Sigma could shed customers after Chemist Warehouse merger

    The deal, creating an $8.8 billion retail and wholesaling giant, could even be blocked by competition regulators, according to analysts at Morningstar.

    • Carrie LaFrenz and Tom Richardson
    Josh and Amie Frydenberg with Laura and Mark Davis at the Australian Open men’s final.

    Sigma’s advisers kept Chemist Warehouse close

    Sigma’s board no doubt pushed for as good a deal as they could get. The motivations of their advisers, though, are complex.

    • Updated
    • Myriam Robin
    Chemist Warehouse

    ‘Like Bunnings’: Fund managers bullish on Chemist Warehouse

    Investors are optimistic that the pharmacy chain is among the best retailers in the country, and has enough room to grow at home to justify its valuation.

    • Tom Richardson
    Jack Gance and Mario Verrocchi are set to storm onto the ASX boards.

    Why Chemist Warehouse creates a quandary for fund managers

    The structure of Chemist Warehouse’s deal with Sigma means fund managers who like the growth story face tough decisions on when and how to get a slice of the action.

    • Updated
    • James Thomson
    HMC Capital’s David Di Pilla and Victoria Hardie lobbed the idea for Chemist Warehouse over a sushi dinner at Nobu in Melbourne.

    How David Di Pilla dreamt up the Chemist Warehouse deal over sushi

    Five months ago, over a sushi dinner at Melbourne’s Nobu, Sigma boss Vikesh Ramsunder and his major shareholder David Di Pilla were toasting a win. Then the lightbulb moment hit.

    • Aaron Weinman

    Copyright © 2024. Company information displayed on The Australian Financial Review is sourced from Morningstar and ASX and is subject to their terms and conditions as set out in our Terms of Use. The Australian Financial Review does not accept any responsibility for the accuracy and/or completeness of such data or information.